ArticleFrontiers in public health2026
Construction and application of a smart hospital platform-based VTE risk management system.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Venous thromboembolism (VTE) ranks as the third most prevalent cardiovascular disease after acute myocardial infarction and stroke, posing a significant risk to patient safety. Clinical challenges such as inadequate VTE awareness among healthcare professionals, low prevention rates, untimely and inaccurate risk assessments, improper grading of preventive measures, and insufficient physician-nurse communication necessitate the development of a more effective management approach. This study aimed to design and implement a smart hospital platform-based VTE risk management system and evaluate its impact on VTE and bleeding risk assessment times, thereby enhancing clinical VTE prevention and control. Methods: A prospective interventional study was conducted to compare outcomes before and after the implementation of the VTE risk management system. The study population comprised inpatients at a tertiary grade A hospital. The pre-implementation cohort included patients admitted from March 1 to June 30, 2024 ( Results: Following system implementation, the time required for nurses to complete VTE risk assessments was reduced from 101.90 ± 15.694 s to 37.18 ± 5.701 s ( Conclusion: The VTE risk management system developed on a smart hospital platform demonstrated marked improvements in risk assessment efficiency and process quality indicators. These findings suggest that the system is feasible and can effectively support standardized VTE management in a real-world hospital setting. However, given the pre-post study design without a concurrent control group, the observed clinical benefits should be interpreted as preliminary trends rather than definitive evidence of effectiveness. Future randomized controlled trials are warranted to confirm the comparative efficacy of this integrated approach.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.